000989 Stock Overview
Provides traditional Chinese, chemical, biological, and health medicine products in China. More details
| Snowflake Score | |
|---|---|
| Valuation | 2/6 |
| Future Growth | 0/6 |
| Past Performance | 3/6 |
| Financial Health | 4/6 |
| Dividends | 2/6 |
My Notes
Capture your thoughts, links and company narrative
Jiuzhitang Co., Ltd. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥7.81 |
| 52 Week High | CN¥10.54 |
| 52 Week Low | CN¥6.10 |
| Beta | 0.50 |
| 1 Month Change | 0% |
| 3 Month Change | 22.22% |
| 1 Year Change | -24.17% |
| 3 Year Change | -27.01% |
| 5 Year Change | -3.58% |
| Change since IPO | -68.80% |
Recent News & Updates
Jiuzhitang Co., Ltd.'s (SZSE:000989) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Nov 14
Weak Statutory Earnings May Not Tell The Whole Story For Jiuzhitang (SZSE:000989)
Nov 07Investors Aren't Buying Jiuzhitang Co., Ltd.'s (SZSE:000989) Earnings
Sep 30Recent updates
Jiuzhitang Co., Ltd.'s (SZSE:000989) Price Is Right But Growth Is Lacking After Shares Rocket 26%
Nov 14Weak Statutory Earnings May Not Tell The Whole Story For Jiuzhitang (SZSE:000989)
Nov 07Investors Aren't Buying Jiuzhitang Co., Ltd.'s (SZSE:000989) Earnings
Sep 30Jiuzhitang (SZSE:000989) Seems To Use Debt Rather Sparingly
Jun 26Shareholder Returns
| 000989 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -0.3% | -1.9% | -1.2% |
| 1Y | -24.2% | -1.8% | 11.8% |
Return vs Industry: 000989 underperformed the CN Pharmaceuticals industry which returned -1.8% over the past year.
Return vs Market: 000989 underperformed the CN Market which returned 11.8% over the past year.
Price Volatility
| 000989 volatility | |
|---|---|
| 000989 Average Weekly Movement | 4.9% |
| Pharmaceuticals Industry Average Movement | 7.4% |
| Market Average Movement | 8.7% |
| 10% most volatile stocks in CN Market | 12.8% |
| 10% least volatile stocks in CN Market | 5.7% |
Stable Share Price: 000989 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 000989's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1999 | 3,519 | Xu Xiang Ping | www.hnjzt.com |
Jiuzhitang Co., Ltd. provides traditional Chinese, chemical, biological, and health medicine products in China. The company offers Shuxuetong injections, Angong Niuhuang pills, Gastrodia Gouteng granules, Danxi granules, and Compound Jiangzhi tablets for cardiovascular and neurological treatment; Nudehua Zizhu tablets, Xiaojin pills, Guizhi Fuling pills, Buxue Shengru granules, and Zhixue Analgesic capsules for the treatment in gynecology; Houyan pills for ear, nose, and throat (ENT) diseases; Jianwei Yuyang tablets for digestion; and prescription drug product systems, Jiaqi Ganxian granules, and Chidan Tuihuang granules for liver diseases. It also provides over the counter (OTC) drugs comprising blood-tonifying, cardiovascular and cerebrovascular, urinary system, pediatric, gynecologic, bone and muscles, respiratory system, dermatologic, nervous system, ENT, and digestive system products; and stem cell and other drugs.
Jiuzhitang Co., Ltd. Fundamentals Summary
| 000989 fundamental statistics | |
|---|---|
| Market cap | CN¥6.61b |
| Earnings (TTM) | CN¥248.98m |
| Revenue (TTM) | CN¥2.65b |
26.6x
P/E Ratio2.5x
P/S RatioIs 000989 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 000989 income statement (TTM) | |
|---|---|
| Revenue | CN¥2.65b |
| Cost of Revenue | CN¥1.10b |
| Gross Profit | CN¥1.56b |
| Other Expenses | CN¥1.31b |
| Earnings | CN¥248.98m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 0.29 |
| Gross Margin | 58.66% |
| Net Profit Margin | 9.38% |
| Debt/Equity Ratio | 3.4% |
How did 000989 perform over the long term?
See historical performance and comparisonDividends
5.1%
Current Dividend Yield137%
Payout RatioCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2024/12/21 05:55 |
| End of Day Share Price | 2024/12/20 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Jiuzhitang Co., Ltd. is covered by 1 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Li Wu | Tianfeng Securities Brokerage Co., Ltd |